ÂÜÀòÂÒÂ×

Dr. Cymbeline (Bem) Culiat studied the genetic and molecular basis of early mammalian development for a decade as a senior scientist at Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (1999-2009). Her research elucidated the role of the NELL1 protein in promoting growth and maturation of the musculoskeletal and cardiovascular systems. This discovery is the foundation on which NellOne Therapeutics (NellOne) was established in 2008. Dr. Culiat is the inventor on 21 patents issued in eight countries, on the veterinary and human applications of NELL1 as a novel therapeutic for soft tissue regeneration. These patents are exclusively licensed worldwide to NellOne, which Dr. Culiat co-founded with former CEO Tracy Warren (General Partner, Battelle Ventures and Astarte Ventures). Bem currently serves as President and Chief Science Officer.

Dr. Culiat is also the co-author of Designed to Heal, where she utilizes her research insights to demonstrate how to heal relational and emotional wounds by exploring the restorative processes of the body.